| |
| |
|
| Insider
Information: |
Menzaghi Frederique Ph.d. |
| Relationship: |
|
| City: |
Shelton |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
167,247 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$113,745 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
167,247 |
|
|
| Total
Value |
$113,745 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cara Therapeutics, Inc. |
CARA |
|
2024-02-01 |
167,247 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CARA |
Cara Therapeutics, Inc. |
CHIEF SCIENTIFIC OFF,SVP-R&D |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
167,247 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2023-06-23 |
4 |
AS |
$3.51 |
$10,505 |
D/D |
(2,993) |
153,747 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2023-04-04 |
4 |
AS |
$4.91 |
$13,419 |
D/D |
(2,733) |
156,740 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2023-03-03 |
4 |
AS |
$9.71 |
$66,047 |
D/D |
(6,802) |
159,473 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2022-12-21 |
4 |
AS |
$11.27 |
$39,513 |
D/D |
(3,506) |
166,275 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2022-04-01 |
4 |
AS |
$11.91 |
$21,247 |
D/D |
(1,784) |
169,781 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2022-02-25 |
4 |
AS |
$10.29 |
$21,753 |
D/D |
(2,114) |
171,565 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
173,679 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
12,607 |
153,679 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-08-30 |
4 |
AS |
$14.20 |
$54,627 |
D/D |
(3,847) |
141,072 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
9,600 |
144,919 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
135,319 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-03-05 |
4 |
AS |
$17.98 |
$60,377 |
D/D |
(3,358) |
119,319 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
122,677 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-02-25 |
4 |
AS |
$19.33 |
$96,708 |
D/D |
(5,003) |
112,677 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2021-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
117,680 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2020-12-30 |
4 |
AS |
$15.30 |
$43,024 |
D/D |
(2,812) |
109,680 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2020-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
112,492 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2020-04-21 |
4 |
AS |
$15.58 |
$200,889 |
D/D |
(12,894) |
104,492 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2020-04-17 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
117,386 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
79,886 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2019-10-25 |
4 |
AS |
$19.91 |
$79,640 |
D/D |
(4,000) |
63,886 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2019-10-18 |
4 |
AS |
$19.33 |
$77,320 |
D/D |
(4,000) |
67,886 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2019-10-11 |
4 |
AS |
$18.70 |
$74,800 |
D/D |
(4,000) |
71,886 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Chief Scientific Off,SVP-R&D |
• – – |
2019-10-04 |
4 |
AS |
$19.19 |
$76,760 |
D/D |
(4,000) |
75,886 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
